Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02DYB
|
||||
| Former ID |
DNC013883
|
||||
| Drug Name |
TRIPTOCALLINE A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526834] | ||
| Formula |
C28H42O4
|
||||
| Canonical SMILES |
CC1CC2C(CCC3(C2(CCC4(C3CCC5=C(C(=O)C(CC54)O)C)C)C)C)(C(<br />C1=O)O)C
|
||||
| InChI |
1S/C28H42O4/c1-15-13-21-26(4,24(32)22(15)30)10-12-27(5)20-8-7-17-16(2)23(31)19(29)14-18(17)25(20,3)9-11-28(21,27)6/h15,18-21,24,29,32H,7-14H2,1-6H3/t15-,18-,19+,20+,21-,24-,25+,26-,27-,28+/m1/s1
|
||||
| InChIKey |
UUGCGHAFZPEHIC-OIOGIDCRSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Aldose reductase | Target Info | Inhibitor | [526834] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||